Related Experiment Video
Updated: Aug 2, 2026
10:05
In vivo 19F MRI for Cell Tracking
Published on: November 25, 2013
In vivo tracking for cell therapies
M Thompson1, D M Wall, R J Hicks
1Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, 1 A'Beckett Street, East Melbourne, Australia 8006.
Summary
Tracking cellular therapies with nuclear medicine imaging is key for optimizing treatment. This approach visualizes cell migration, ensuring effective delivery and therapeutic response for improved patient outcomes.
Area of Science:
- Nuclear medicine
- Cellular therapy
- Medical imaging
Background:
- Cellular therapy success depends on agent migration, number, and response.
- Optimizing therapy is complex due to numerous production, administration, and host variables.
- Direct visualization of in vivo cell migration is crucial for assessing these variables.
Purpose of the Study:
- To highlight the importance of imaging techniques for evaluating cellular therapy efficacy.
- To emphasize the benefits of nuclear medicine, particularly PET imaging, for tracking cell migration.
- To advocate for the early integration of cell tracking studies into clinical trials.
Main Methods:
- Utilizing conventional radionuclide cell labeling for biodistribution.
- Employing Positron Emission Tomography (PET) isotope labeling for enhanced sensitivity and resolution.
- Conducting imaging studies to visualize and quantify in vivo cell migration patterns.
Main Results:
- Imaging studies provide definitive evidence of successful targeting.
- Quantification of cell migration to specific sites is achievable.
- Tracking studies allow for patient-by-patient evaluation of therapeutic variables.
Conclusions:
- Direct visualization via nuclear medicine significantly aids in appraising factors affecting cellular therapy.
- PET imaging offers superior sensitivity and resolution for cell tracking.
- Integrating cell tracking into early clinical trials provides proof of mechanism and facilitates therapy optimization.
